Unibest
← Back to patent-cliff list

Yttrium[90Y]

Tier C — Watch / trade

Yttrium[90Y]

-
Originator
2002
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:Not applicable

Brand:SIR-Spheres

Indications (approved):Liver cancer, Colorectal cancer

Regional status

US
Approved
2002-03-01
EU
Approved
2002-01-01
China
Approved
2022-01-30
Japan
-

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Yttrium[90Y]?

Approved indications include: Liver cancer, Colorectal cancer.

When does the Yttrium[90Y] patent expire?

No public expiry year is available for Yttrium[90Y] yet; this page updates once verified.

How do I get a quote for Yttrium[90Y] intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27